Condition: Non-alcoholic Steatohepatitis · Sponsor: Novo Nordisk A/S
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will either get semaglutide or a dummy medicine - which treatment participants get is decided by chance. Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week. The study will last for about 5 years. Participants will have up to 21 clinic visits and 9 phone calls with the clinical staff during the study. Some of the clinic visits may be spread over more than one day. Participants with other chronic liver diseases cannot take part in this study. Women cannot take part in the study if they are pregnant, breast-feeding or plan to become pregnant during the study period.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| North AL Health Res, LLC | Huntsville, Alabama, United States | — |
| The Institute for Liver Health | Chandler, Arizona, United States | — |
| Inst-Liver Hlth dba AZ Liver H | Peoria, Arizona, United States | — |
| Inst. Liver H II dba AZ Liver H | Tucson, Arizona, United States | — |
| Del Sol Research Management, LLC | Tucson, Arizona, United States | — |
| ARcare Center for Clinical Research | Jonesboro, Arkansas, United States | — |
| ARcare Center for Clinical Research | Little Rock, Arkansas, United States | — |
| Arkansas Diagnostic Center, PA | Little Rock, Arkansas, United States | — |
| Gastroenterology & Liver Institute | Escondido, California, United States | — |
| Shang Wu M.D. Inc. | Hacienda Heights, California, United States | — |
| Scripps Whittier Diabetes Inst | La Jolla, California, United States | — |
| UCSD NAFLD Research Center | La Jolla, California, United States | — |
+ 545 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.